Beyond prostate cancer cell lines, we also observed a significant reverse correlation between EZH2 and HNF1B expression in patient samples, and the high EZH2 and low HNF1B pattern is strongly associated with poor prognoses and advanced metastatic state (our own collection and public database). The gene discussed is EZH2; the disease is prostate carcinoma.